undergoes marked structural change throughout normal pregnancy and becomes elongated significantly. It is composed of a mixture of myocytes from body and fibroblasts with extracellular matrix which forms the passive lower uterine segment during labor in vaginal delivery. However, its contribution to uterine contractile dysfunction involving PAM is still unknown. Our aim is to investigate isthmus tissue of PAM cases and find its involvement in the inflammatory changes observed in uterus affected by AFE. STUDY DESIGN: Under the AFE Registry Program in Japan, all AFE cases are registered and investigated in our university in the department of OBGY. We investigated isthmus tissue of these cases and performed immunohistochemistry for inflammatory cell markers-Neutrophil elastase, mast cell tryptase, CD68, CD3 and C5a receptor and observed their expression. Control isthmus tissues were obtained from elective cesarean section patients from the site of lower uterine incision. Winroof software (Mitani Corporation) was used for image analysis and Mann Whitney U test for statistical analysis. RESULTS: A significant number of degranulating mast cells were observed in PAM isthmus as compared to controls (P<0.05) indicating an anaphylactoid reaction in AFE. The number of infiltrating neutrophils in PAM was also significantly more than controls (P<0.001) showing an acute inflammatory reaction in the uterus. CONCLUSION: Marked inflammatory changes were observed both in isthmus and myometrium in the uterus involving AFE which suggests broad development of inflammation, possibly leading to severe uterine atony and postpartum hemorrhage. 
OBJECTIVE:
We have shown that in otherwise healthy women, body mass index (BMI) 40 kg/m 2 is independently associated with adverse neonatal outcomes; however, delivery <39-40 weeks for this indication alone further increases morbidity. It is unclear if increasing BMI has additive adverse perinatal effects when added to common comorbidities like hypertension (HTN) and/or diabetes (DM). We sought to evaluate if increasing BMI class is associated with worsening perinatal outcomes in women with HTN and/or DM delivered by pre-labor elective repeat cesarean delivery (ERCD) and to identify the gestational age (GA) at birth between 37-39 weeks at which these morbidities are minimized. STUDY DESIGN: We performed a secondary analysis of a prospective cohort of women undergoing ERCD performed at 19 centers in the MFMU from 1999-2002. Women with HTN and/or DM and nonanomalous singletons delivered by term pre-labor ERCD were included. Women with comorbidities other than HTN or DM or non-elective CD were excluded. Primary outcome was composite neonatal morbidity; secondary outcomes included composite maternal morbidity and individual components of the composites (Table) . Incidences of outcomes were calculated for women with HTN, DM, and HTN and/or DM and stratified by BMI class. Multivariable logistic regression was used to calculate adjusted ORs (with 95% CIs) with BMI <30 as reference. Mantel-Haenszel test was used to evaluate the relationship between BMI class and each comorbidity stratified by week GA at delivery. RESULTS: Of 13350 women who underwent ERCD, 786 with documented BMI and either HTN, DM, or HTN and/or DM were analyzed. There was no significant difference in composite neonatal morbidity (or individual components) by BMI class in women with HTN, DM, or HTN and/or DM (Figure /Table) . However, there was increasing composite maternal morbidity (p¼NS) and a significant increase in incidence of wound complications (p¼0.04) with increasing BMI class in women with HTN and/or DM. There were no significant relationships between BMI class, HTN and/or DM, and any outcome across week GA at delivery (p¼NS). CONCLUSION: While BMI 40 increases neonatal morbidity in healthy women, there appears to be no additive effect of increasing BMI class, regardless of GA at delivery, in women with HTN and/or DM.
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